Silverarc Capital Management, LLC Unicycive Therapeutics, Inc. Transaction History
Silverarc Capital Management, LLC
- $411 Million
- Q1 2025
A detailed history of Silverarc Capital Management, LLC transactions in Unicycive Therapeutics, Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 2,413,489 shares of UNCY stock, worth $12 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
2,413,489
Previous 2,486,709
2.94%
Holding current value
$12 Million
Previous $1.96 Million
29.99%
% of portfolio
0.33%
Previous 0.47%
Shares
3 transactions
Others Institutions Holding UNCY
# of Institutions
31Shares Held
59.9MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA11.4MShares$56.5 Million1.76% of portfolio
-
Great Point Partners LLC Greenwich, CT11MShares$54.6 Million3.87% of portfolio
-
Octagon Capital Advisors LP New York, NY10MShares$49.7 Million1.9% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT9.39MShares$46.7 Million0.24% of portfolio
-
Logos Global Management LP San Francisco, CA5.08MShares$25.2 Million0.56% of portfolio
About Unicycive Therapeutics, Inc.
- Ticker UNCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,052,500
- Market Cap $74.8M
- Description
- Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Al...